• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次剂量的皮质类固醇能降低内镜逆行胰胆管造影术后胰腺炎的发生率吗?一项随机、前瞻性对照研究。

Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study.

作者信息

Kwanngern Kris, Tiyapattanaputi Prawes, Wanitpukdeedecha Mongkol, Navicharern Patpong

机构信息

Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

J Med Assoc Thai. 2005 Sep;88 Suppl 4:S42-5.

PMID:16623000
Abstract

BACKGROUND

Acute pancreatitis is one of the complications after Endoscopic retrograde cholangio pancreatography (ERCP) and it could be fatal. Several drugs were used to prevent or decrease this complication. Corticosteroid is one of the medications which may have such potential. It is affordable and available everywhere.

OBJECTIVES

To compare the incidence of post-ERCP pancreatitis in patients receiving single dose corticosteroid prior to the procedure with that of the control group .

RESEARCH DESIGN

A prospective randomized controlled double-blinded study.

MATERIAL AND METHOD

A total of 120 patients were randomized to receive either intravenous hydrocortisone 100 mg. or normal saline 1 hour prior to the procedure. The serum amylase levels were recorded 4 and 24 hours after the procedure. Abdominal pain and back pain were also recorded. Patients were diagnosed as having post-ERCP pancreatitis if ones had new or worsened epigastric pain with or without radiation to the back combined with elevation of serum amylase more than 2.5 times the upper limit.

RESULTS

The overall incidence of pancreatitis was 6.67% with 1.64% in the study group compared with 11.86% in the control group (p = 0.031). The groups were similar with regard to age, gender, type of procedure performed (diagnostic or therapeutic), difficulty of cannulation, concentration of contrast media and pre operative amylase level.

CONCLUSION

The results of the present trial indicate that hydrocortisone could reduce the risk of post-ERCP pancreatitis.

摘要

背景

急性胰腺炎是内镜逆行胰胆管造影术(ERCP)后的并发症之一,可能会致命。有几种药物被用于预防或减少这种并发症。皮质类固醇是可能具有这种潜力的药物之一。它价格低廉且随处可得。

目的

比较术前接受单剂量皮质类固醇治疗的患者与对照组患者ERCP术后胰腺炎的发生率。

研究设计

一项前瞻性随机对照双盲研究。

材料与方法

总共120例患者被随机分为两组,一组在手术前1小时静脉注射100毫克氢化可的松,另一组注射生理盐水。在手术后4小时和24小时记录血清淀粉酶水平。同时记录腹痛和背痛情况。如果患者出现新的或加重的上腹部疼痛,伴有或不伴有背部放射痛,且血清淀粉酶升高超过上限的2.5倍,则诊断为ERCP术后胰腺炎。

结果

胰腺炎的总体发生率为6.67%,研究组为1.64%,对照组为11.86%(p = 0.031)。两组在年龄、性别、手术类型(诊断性或治疗性)、插管难度、造影剂浓度和术前淀粉酶水平方面相似。

结论

本试验结果表明,氢化可的松可降低ERCP术后胰腺炎的风险。

相似文献

1
Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study.单次剂量的皮质类固醇能降低内镜逆行胰胆管造影术后胰腺炎的发生率吗?一项随机、前瞻性对照研究。
J Med Assoc Thai. 2005 Sep;88 Suppl 4:S42-5.
2
Risk factors for post-ERCP pancreatitis: a prospective multicenter study.内镜逆行胰胆管造影术后胰腺炎的危险因素:一项前瞻性多中心研究。
Am J Gastroenterol. 2006 Jan;101(1):139-47. doi: 10.1111/j.1572-0241.2006.00380.x.
3
Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study.皮质类固醇在预防内镜逆行胰胆管造影术后胰腺炎中的应用:一项对照前瞻性研究的结果
Am J Gastroenterol. 1999 Apr;94(4):982-5. doi: 10.1111/j.1572-0241.1999.999_u.x.
4
Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.内镜逆行胰胆管造影术后胰腺炎和高淀粉酶血症:患者相关及手术风险因素
Endoscopy. 2002 Apr;34(4):286-92. doi: 10.1055/s-2002-23630.
5
Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.重组血小板活化因子乙酰水解酶用于降低内镜逆行胰胆管造影术后急性胰腺炎发生率及严重程度的评估。
Gastrointest Endosc. 2009 Mar;69(3 Pt 1):462-72. doi: 10.1016/j.gie.2008.07.040.
6
Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.术后给予甲磺酸加贝酯预防内镜逆行胰胆管造影术后胰腺炎的疗效:一项随机、对照、多中心研究。
Gastrointest Endosc. 2007 Jun;65(7):982-7. doi: 10.1016/j.gie.2007.02.055.
7
Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.吲哚美辛可能会降低内镜逆行胰胆管造影(ERCP)术后急性胰腺炎的发生率和严重程度。
Am J Gastroenterol. 2007 May;102(5):978-83. doi: 10.1111/j.1572-0241.2007.01165.x. Epub 2007 Mar 13.
8
Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.甲磺酸萘莫司他预防内镜逆行胰胆管造影术后胰腺炎及术后胰腺炎的危险因素
Gastrointest Endosc. 2009 Apr;69(4):e11-8. doi: 10.1016/j.gie.2008.10.046.
9
Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.硝酸甘油用于内镜逆行胰胆管造影术所致胰腺炎的前瞻性随机双盲安慰剂对照试验
Br J Surg. 2001 Sep;88(9):1178-82. doi: 10.1046/j.0007-1323.2001.01842.x.
10
A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.一项关于泼尼松和别嘌醇预防内镜逆行胰胆管造影术(ERCP)诱发胰腺炎的前瞻性、随机、安慰剂对照试验。
Endoscopy. 2001 Sep;33(9):766-72. doi: 10.1055/s-2001-16520.

引用本文的文献

1
Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.内镜逆行胰胆管造影术相关胰腺炎:一项15年的回顾。
World J Gastrointest Endosc. 2010 May 16;2(5):165-78. doi: 10.4253/wjge.v2.i5.165.
2
Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis.内镜逆行胰胆管造影术后胰腺炎预防性使用皮质类固醇的荟萃分析。
BMC Gastroenterol. 2008 Feb 14;8:6. doi: 10.1186/1471-230X-8-6.
3
Pancreatitis after endoscopic retrograde cholangio-pancreatography.内镜逆行胰胆管造影术后胰腺炎
World J Gastroenterol. 2007 May 21;13(19):2655-68. doi: 10.3748/wjg.v13.i19.2655.